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Abstract
Background: The present study protocol describes the evaluation of a comprehensive integrated care model
implemented at two hospital sites at the University Hospital of North Norway (UNN). The PAtient Centred Team
(PACT) model includes proactive, patient-centred interdisciplinary teams that aim to improve the continuum and
quality of care of frail elderly patients and reduce health care costs. The main objectives of the evaluation are to
analyse the effectiveness and cost effectiveness of using patient-centred teams as part of routine service provision
for this patient group. The evaluation will analyse the effect on patient health and functional status, patient
experiences and hospital utilisation, and it will conduct an economic evaluation. This paper describes the PACT
model and the rationale for and design of the planned effectiveness and cost-effectiveness study.
Methods/design: This is a prospective, non-randomised matched control before-and-after intervention study.
Patients in the intervention group will be recruited from the hospital sites that have implemented the PACT model.
The controls will be recruited from two hospitals without the model. The control patients and the index patients
will be matched according to sex, age and number of long-term conditions. The study aims to include 600 patients
in each group, which will provide sufficient power to detect a clinical change in the primary outcome. The primary
outcome is the physical dimension of the Short Form Health Survey (SF-36). Secondary outcomes are the Patient
Generated Index (PGI), the Patient Activation Measure (PAM), the Patient Assessment of Chronic Illness Care (PACIC),
hospitalisation and length of stay. The cost-effectiveness study takes a health provider perspective and calculates
the cost per quality-adjusted life-years (QALYs) gained. The data will be collected at baseline, 6 and 12 months. The
data will be analysed using techniques and models that recognise the lack of randomisation and the correlation of
cost and effect data.
Discussion: The study results will provide knowledge about whether the integrated care model implemented at
UNN improves the quality of care for the frail elderly with multiple conditions. The study will establish whether the
PAC. T model improves health and functional status and is cost effective compared to the usual care for this
patient group.
Trial registration: ClinicalTrials.gov: NCT02541474
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Background
As the population ages, the proportion of older persons
admitted to hospital is continuously increasing. Older
people are found to have higher admission rates and lon-
ger hospital stays than the general population [1]. Pa-
tients aged 67 years and older account for 35 % of the
hospital admissions in Norway [2]. This is comparable
to other countries. Persons aged 65 and over account for
approximately 38 % of the hospital admissions in the
United Kingdom [1] and 36 % in the United States [3].
Older people are also major consumers of hospital-
based acute services [4]. The current disease-oriented
and episodic models of care do not adequately respond
to the complex care needs of older patients [5] and pa-
tients with multimorbidity [6]. Compared with younger
persons, older adults have longer stays, their visits have
a greater level of urgency, they are more likely to be re-
admitted, and they experience higher rates of adverse
health outcomes after discharge [5]. Studies show that
there is a considerable risk of adverse events in relation
to the transition of patients between hospitals and pri-
mary care services and that information exchange at dis-
charge is often insufficient [7, 8]. Thus, there is a
growing need for better care coordination between and
within primary and specialist health care services to en-
sure patient safety and continuity of care [9].
The efficient and effective management of acutely ill,
complex inpatients poses one of the greatest challenges
in current hospital care [10]. Health care utilisation and
costs increase significantly with increasing number of
chronic conditions [11]. One way to improve the man-
agement of the older patients with multimorbidity is to
use patient-centred interdisciplinary teams. Interdiscip-
linary team work offers an integrated approach to pro-
viding coordinated health care to “high-risk” patients
with complex long-term needs. Team work has been
considered good practice for more than two decades
[12]. However, little evidence exists that these types of
interventions are effective. Five recent systematic re-
views found mixed results and they reported that there
exists no clear evidence that these interventions are ef-
fective or cost effective [4, 13–16]. These reviews re-
ported that some well-integrated models have improved
the process of care and have the potential to reduce hos-
pitalisation and nursing-home use [13]. Some of the
studies also reported improved prescribing and medica-
tion adherence [14]. One of the reviews that specifically
looked into the cost effectiveness of multidisciplinary
teams found the same trend of insufficient evidence.
This review reported mixed results and a high degree of
heterogeneity and low-quality evaluations [15]. All these
reviews concluded that more research is needed in this
area. They also argued that comparison among studies is
difficult because of the heterogeneity in both how
interdisciplinary teams work and the study populations
analysed. This hampers the ability to develop best-
practice models.
In our local setting, a recent report documented that
two of the main challenges are the lack of attention to
the personal context of the patients and the fragmented
care delivery [17]. The need for a re-design of care deliv-
ery with more service integration and improved follow-
up regimen seems particularly urgent for frail elderly pa-
tients with complex and long-term needs [18–20]. A
large-scale project that facilitates more integrated and
coordinated care for frail elderly medical patients is now
under development at the University Hospital of North
Norway (UNN). The Patient-Centred Team (PACT)
model is being established at UNN Tromsø, UNN Har-
stad and their hosting municipalities. The purpose of the
PACT model is to improve the continuum and quality
of care for frail elderly patients and to reduce health care
costs. The PACT model has been initiated and is solely
driven by managers and clinical personnel at the hospital
and at the community services.
The PACT model is inspired by the Chronic Care
Model (CCM) and builds on two pillars. These are “the
informed active patient” and “the pro-active prepared
health care team”, engaging in “productive interactions”
for “health and functional outcomes”. Both health man-
agement’s support and use of information and commu-
nication technology (ICT) are key supporting factors
[21]. There is a growing evidence base for CCM’s effects
on both care processes, health outcomes [22, 23] and
cost savings [24]. CCM continues to inspire care reforms
internationally [25, 26]. The Norwegian health author-
ities are pushing for a large system transformation to-
wards a truly person-oriented integrated care model
which broadly aligns with CCM-principles [18].
The present paper describes the effectiveness- and
cost-effectiveness evaluation of the PACT model. The
main aim of the evaluation project is to determine
whether the PACT model improves health and func-
tional status and is cost effective compared to usual care.
First, we describe the PACT model now being imple-
mented as part of routine care at two hospitals in north-
ern Norway and their hosting municipalities. Second, an
overview of the design and methods used in the effect-
iveness study and the economic evaluation is provided,
followed by a brief discussion. The evaluation project is
funded by a research grant from the regional health au-
thorities Helse Nord (Grant No. HST1242/3-15).
The PACT model
The PACT model is a comprehensive integrated care
model that aims to ensure safe discharge and prevent
hospital admissions for frail elderly patients with
multiple conditions. The patient-centred and proactive
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interdisciplinary teams, which include both the commu-
nity services and hospital staff, are the key element of
the model. The main task of the team is to follow pa-
tients through the system and help them receive appro-
priate and timely health care services when needed at
the most appropriate location. The team will include the
patients and their families in planning and facilitating
service integration. The patients will be actively involved
in defining goals, assessing needs and making care plans
and follow-up protocols. Patient involvement and en-
gagement in care has been shown to improve health and
functional outcomes [27]. The team will identify and as-
sess needs early, provide support during discharge and
follow-up, facilitate coordination and integrated services
across the levels of care and support, and care for the
patients outside the hospital. This might ease the transi-
tion, reduce unplanned hospital admissions, reduce the
need for community services and improve or avoid de-
terioration in patient health outcomes.
The PACT model includes five main tasks: to identify
the patients with a special need for coordinated care; to
identify patient goals and conduct need assessments; to
facilitate individualised care plans and tailored follow-up
protocols; and to initiate meetings regarding the coord-
ination and integration of patient care across service
providers. In particular, the team will assess the risk of
fall and the need for special aid and review medication
lists. The team will also ensure that general practitioners
(GPs) are informed and included in the planning
process. The patients will remain a team responsibility
until the community service provider has established ap-
propriate care or until the patients can manage at home
without help.
The core team consists of the team leader (ICL) and
two full-time coordinators: one from the hospital and
one from the community service. The core team will be
responsible for the day-to-day management of the team-
work and ensuring that the patients receive appropriate
and timely support and services. The interdisciplinary
team further consists of a senior medical doctor, geriat-
ric nurses, district nurses, physiotherapists, occupational
therapists and one pharmacologist.
The local implementation and structure of the PACT
model will vary between the two experimental regions,
even if the service model has a formal selection proced-
ure and a common core of services. The structure and
organisation of the service model will cover complex
areas such as patient logistics (regulating the patient
flow through the system; knowing when and how block-
ages occur and resolving them; using various instru-
ments, such as case management; discharge protocols;
capacity constraints; and home monitoring and support
with various means). Information logistics, such as team
communication and information exchange, will also
vary. The general aim of the PACT model, however, will
be the same: to ensure that the patients receive the right
treatment and care at the right time and in the most
suitable location.
Status
At the time of writing, all team members, including a
part-time recording secretary, have been appointed at
the hospital in Tromsø. The test and developing phase is
well underway. The team is now actively promoting their
existence and services by visiting GPs, district nurses,
other community service providers and hospital wards
and clinics. The first patients have been referred to the
team as part of the test phase, but no patients have yet
been enrolled in the trial. The team has been assigned
office space at the hospital and has scheduled two daily
meetings to plan activities and discuss patients. In be-
tween team meetings, the team is conducting home
visits, attending coordination meetings, writing case re-
ports and updating patient records. The second hospital
has finished the planning phase and will be operational
by fall 2015.
Methods/design
Objectives and research questions
The main objective of the evaluation is to analyse the ef-
fectiveness and cost effectiveness of establishing patient-
centred interdisciplinary teams (the PACT model) as
part of routine health care delivery for frail elderly pa-
tients with multiple conditions. The evaluation will ana-
lyse the effect of the PACT model on patient health and
functional status, patient experiences and hospital util-
isation, and we will conduct an economic evaluation.
The research questions (RQs) include the following:
Effectiveness evaluation
1. Does the PACT model affect the health outcomes
and functional status of the patients?
2. Does the PACT model improve patient experiences
and have an impact on the areas in life that the
patients themselves consider important?
3. Does the PACT model reduce unplanned hospital
admissions and length of stay?
Cost-effectiveness evaluation
4. Does the PACT model represent cost-effective
resource use from a health provider perspective in
the short term (trial-based evaluation)?
5. Is the PACT service model more cost effective for
any specific subgroups of patients, defined by age,
conditions (diagnoses), co-morbidities and other
baseline factors?
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6. Is the PACT model cost effective in a 10-year
perspective (model-based evaluation)?
Design
This evaluation study is a prospective non-randomized,
matched control, before-and-after study [28]. We will
compare all hospitalised patients meeting the inclusion
criteria with patients receiving usual care in a control
setting. The PACT model is directed at the organisa-
tional level or geographic site, affecting all patients
within the uptake area. Therefore, the intervention and
controls are separated in different hospitals to avoid
contamination. The chosen design improves comparabil-
ity between the patient populations by matching them
on factors known to be important for outcomes (age, sex
and number of conditions), adjusting for baseline differ-
ences between the populations with a before-after design
and adjusting for known confounders by the propensity
score method [29, 30].
Participants
The intervention group participants will be recruited
consecutively until we have reached the target of 600 pa-
tients. As soon as the patients have signed the consent
form, the intervention will start and the baseline data
collection will begin. The follow-up period will be one
year from the initial assessment for each patient.
 Inclusion criteria: Patients with emergency
admission to the UNN internal medicine
department in Tromsø and Harstad who are over
the age of 65 years, have two or more long-term
conditions and provide valid written informed
consent (either by the patient or the next of kin).
 Exclusion criteria: Language barriers, life expectancy
of less than three months and unable to provide
written informed consent.
The control population will be recruited from the
Nordland Hospital in Bodø and from the hospital UNN
Narvik. When an index patient is identified in the hospi-
tals using patient-centred teams, at least two eligible pa-
tients from the control hospitals will be identified. Sex,
age and number of long-term conditions will be used to
match the control patients to the index patients. The
control patients will be subject to the same data collec-
tion as the intervention patients.
Sample size
The sample size calculation is based on the primary
outcome measure: the Short Form Health Survey (SF-
36). The SF-36 has a range from 0 to 100, where 100
is the best possible score, and a standard deviation
(SD) of approximately 25 in other populations. Points
of two have been shown to be clinically significant
[31]. Two different geriatric integrated care interven-
tions similar to ours found differences of 4–6 points
between intervention and control groups [32, 33]. We
wish to be able to detect a difference of four points
in the SF-36 physical health dimension between the
intervention and control groups. With 600 patients in
each group and a statistical significance level of 0.05,
we will have a power of 0.80 to detect such a differ-
ence between the groups. We expect this to be realis-
tic based on the existing hospital admission rates.
The intervention and control hospitals had approxi-
mately 9500 medical emergency admissions for pa-
tients aged 67 years and older in 2014 [2].
Setting
Trials are often performed on selected patients without
comorbidities, causing studies to suffer from limited ex-
ternal validity [34]. Van Royen et al. (2014) argue that
there is a driving demand for real-word clinical practice
data [35]. In this project, the team members will develop
the PACT working routines as part of the daily activities
at the hospitals. The model will include medical patients
over 65 from an everyday clinical setting, making the
trial context naturalistic. The real-world setting and nor-
mal patient caseload make the design resemble usual
care, thus increasing the generalisability from the trial to
other patients in regular practice.
Outcome measures
The outcomes measures need to match the desired ef-
fects of the intervention: the triple aim of improved
health and function, improved patient experience and
lower costs. The primary outcome is the adjusted differ-
ences in the change in the physical health dimension of
the Short Form-36 (SF-36) between the intervention and
the control groups.
The secondary outcomes are the other dimensions of
the SF-36 instrument, health resource use (to measure
the costs both in primary and secondary care) and the
patient-generated index (PGI) [36]. The PGI registers
the patient’s own health complaints at baseline and the
severity of these at baseline and follow-up points (the
PGI-open format) [37]. The Patient Activation Measure
[38] will also be used to measure health self-efficacy. We
will use the Patient Assessment of Chronic Illness Care
Questionnaire (PACIC) adapted for the Norwegian con-
text [39] to measure how well the patients think the ser-
vice has been able to support pro-active patient centred
care.
Other variables that will be collected are self-reported
background information on life-style, socio-economic
status and previous health care experiences.
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Data collection and management
Each hospital will have a part-time study nurse based in
the geriatric department. The study nurses will adminis-
ter the consent forms and support the data collection
from the patients. The background variables and all the
questionnaires will be completed by the patients at base-
line, 6 and 12 months.
All data on health service use, including medication,
will be collected from electronic information systems.
Data on hospital use (hospital admission, length of stay,
outpatient consultation, emergencies and medication)
will be collected from the hospital records. Data on pri-
mary health resource use will be collected from the GPs,
the municipalities and other available information sys-
tems. Data from the municipalities will supplemented by
interviews with the providers. The cost associated with
the PACT model itself will be determined by interview-
ing the PACT members (staff ) and reviewing budgets.
Effectiveness evaluation
Health and functional status
To measure health and functional status, the SF-36 was
chosen. This is an instrument which researchers across
the world have used to describe health-related quality of
life in over 4000 publications [40]. Its validity and reli-
ability are high and well documented [41]. The question-
naire has eight domains: physical function, role-physical,
bodily pain, general health, vitality, social functioning,
role-emotional and mental health. Since the patients in
this study will be recruited in a somatic-care setting, the
physical function sub-domain has been chosen as the
primary outcome measure. The other domains are sec-
ondary outcomes.
The scores of the SF-36 do not follow a normal dis-
tribution, yet the accepted convention among authors
is to use means, standard deviations and ANOVA in
statistical analyses. This is possible and desirable be-
cause of the high robustness of these statistical
methods in the face of non-normal distributions, and
because they allow comparison of results with previ-
ously published results [42].
Patient experiences
The CMM-theory assumes that patients who experience
a person-centred approach are more likely to have their
personal goals addressed. Furthermore, the CMM as-
sumes that person centeredness improves self-efficacy
for health issues and that the patients experience care
and service provision that is more sensitive to their
needs. The instruments we will use to assess patient ex-
periences are listed below.
The PGI [36] will be used to measure the patients’ per-
sonal goal attainment. The PGI registers patients’ own
health complaints and their severity at baseline and
follow-up [37].
The Patient Health Activation (PAM) instrument will
be used to measure self-efficacy. The concept of an in-
formed active patient presumes that if we support a per-
son in their management of their own condition, this
will translate into better health and functioning. How-
ever, self-management is contingent on motivation,
knowledge and skills [38].
The PACIC will be used to assess if the PACT model
is in accordance with the pillars of the CCM. The
PACIC is developed to measure the presence of patient
engagement in self-management, patient involvement in
the development of a care plan and the degree of indivi-
dualised goal setting. The instrument also measures the
presence of identifying and solving barriers during care
plan implementation as well as the degree of progress of
and revisions to the care plan [39]. The PACIC has been
validated, shows good reliability and has been widely
used. However, correlations between high PACIC scores
and care outcomes vary [43–46]. Recent publications in-
dicate that CCM-care is especially important among dis-
advantaged patients, such as minority groups and
patients with a low health activation [44, 47]. In the ab-
sence of any other instrument for the purpose of meas-
uring fidelity to CCM-care, we will use the PACIC
questionnaire to determine experienced fidelity to the
CCM and to explore the interaction with the results col-
lected by the PAM instrument.
Service use
Hospital admission and length of stay will be used as
intermediate outcome measures to assess how the PACT
model affects hospital utilisation.
Analyses
The analyses will use an intention-to-treat approach that
includes all participants who signed the informed con-
sent at the intervention and control hospitals. Missing
data will be imputed using multiple imputations [48].
The multiple imputation model will include predictors
from all time points, including health-related quality of
life (SF-36), background variables, trial-related variables
and resource use at baseline. Results with and without
imputed data will be reported. The data will be analysed
as a synthetic randomised controlled trial (RCT), using
the propensity score method. This method postulates
that each patient has a basic probability of the outcome
of interest based on his/her characteristics [29]. Based
on available knowledge for each patient (e.g. age, sex,
education, ethnicity), we can calculate the patient’s pro-
pensity for the outcome (i.e. change in QoL). In subse-
quent analyses, we stratify analyses by this score. Within
each stratum, the only known difference between
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patients with respect to the outcome will be the patient-
centred teams. The fundamental requirement for validity
in a causal analysis is that the variables used to create
the propensity score are independent of the probability
of getting the intervention. In common-sense terms, this
means that in the synthetic study, within the same pro-
pensity score strata, the assignment to treatment is
essentially the same as if it had been done by
randomisation.
Cost-effectiveness evaluation
Trial-based economic evaluation
The trial-based economic evaluation consists of a cost-
utility analysis with a time horizon of 12 months. The
analysis takes a health provider perspective and collects
data on health resource use and health outcomes mea-
sured in quality-adjusted life-years (QALYs). The eco-
nomic evaluation will be conducted in accordance with
the CHEERS statement [49].
For the economic evaluation, health outcomes will be
measured using the SF-6D instrument [50]. The SF-6D
will be extracted from the SF-36 and will include phys-
ical functioning, role participation (combined role-
physical and role-emotional), social functioning, bodily
pain, mental health and vitality. The algorithm by Bra-
zier et al. will be used to transform the scores into utility
values [51]. The SF-6D scores will be transformed to
QALYs by weighing the per-period estimates of utility
scores with the time spent in the particular health state,
assuming a linear change in utility over time. Imbalances
in baseline values will be adjusted for using multiple re-
gression [52].
Only health care costs assumed to be affected by the
PACT model and of potential economic significance will
be included in the main analysis. Costs borne by patients
and productivity losses to society are considered less
relevant for the patient group in this study. Two main
cost components will be included: the costs related to
the PACT model (technology and personnel costs) and
the cost related to health services use over the course of
the trial (hospital inpatient, outpatient, day hospital and
emergency services, community-based health care ser-
vices and medication). Cost weights will be applied to
calculate the costs associated with each primary and sec-
ondary health resource activity. These will be collected
from hospital accounting databases, national tariffs and
official wage and price lists.
The cost-utility analysis will be based on the net-
monetary benefit framework (NMB). The NMB ap-
proach allows for modelling the variability in the cost
effectiveness between the centres and GPs [53]. NMB re-
gression will be used to analyse whether the PACT
model is more cost effective for a specific subgroup of
patients (the effect modification in RQ 5).
The data will be analysed using appropriate techniques
that account for the correlation between cost and effect
data. Trial-wide costs, QALYs and incremental cost-
effectiveness ratios will be reported, as will hospital-
specific estimates. If the economic evaluation finds that
one option ‘dominates’ the other with a negative incre-
mental costs (costs less) and a positive incremental effect
(produces more QALYs), this will considered the most
cost-effective option. If better outcomes are associated
with higher costs, an incremental cost effectiveness ratio
(ICER) will be calculated [54]. Cost effectiveness will
then be assessed based on different willingness-to-pay
(WTP) thresholds.
Sampling uncertainty will be handled through the use
of p-values and confidence intervals (CIs) for costs,
QALYs and incremental cost-effectiveness ratios. Confi-
dence intervals for the mean differences in costs and
effects between groups will be calculated using non-
parametric bootstrap simulation. Cost-effect pairs will be
plotted in the cost-effectiveness plane and show the
95 % confidence regions for the ratio. A range of differ-
ent thresholds will be analysed using a cost-effectiveness
acceptability curve.
Non-sampling uncertainty will be handled in sensitiv-
ity analyses. The most uncertain methodological as-
sumptions will be varied to illustrate the robustness of
the results. Sensitivity analyses will be performed on per-
spective (societal versus health provider) and different
willingness-to-pay values.
Model-based economic evaluation
Decision modelling will be used to address cost effect-
iveness beyond the 12-month study period. A Markov
model will be developed to calculate the costs and
QALYs with a 10-year time horizon. The model will
combine the results from the trail-based analysis with
data from the literature and official Norwegian statistics.
Future costs and QALYs will be discounted according to
Norwegian guidelines for health economic evaluations
[55]. Probabilistic sensitivity analysis will be conducted
to test parameter uncertainty and construct cost-
effectiveness acceptability curves.
Ethics
The study has been granted ethical approval by the Re-
gional Committees for Medical and Health Research
Ethics in Norway (REK No. 2014/1707). We have been
granted approval to use electronic hospital record (EHR)
data to identify potential controls so that invitations to
participate in the trial can be issued. We have also been
granted approval to include patients unable to provide
informed consent (due to cognitive impairment) as long
as the next of kin provides informed consent on the pa-
tient’s behalf. All data will be temporarily stored on a
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secure research server at UNN. The local data protec-
tion supervisor has approved the study. The trial has
been registered at ClinicalTrials.gov.
Discussion
The PACT model is now being established at two hos-
pital in the northernmost region in Norway. It is a com-
prehensive integrated care model that aims to ensure the
safe discharge and prevent hospital admissions of frail
elderly patients with multiple conditions. As part of the
PACT intervention, a research project evaluating the effect
on patients’ health and functional status, health resource
use and costs will be carried out. The present paper has
described the PACT model and the rationale for and
design of the effectiveness and cost-effectiveness study.
The project boasts the committed engagement of
leaders and health personnel from all three main health
care organisations in the area. The municipal nursing
services, the GP-services and the specialist services of the
hospitals are collaborating to improve service integration.
The implementation of patient-centred teams is financed
as a cost-sharing collaborative, where all three health orga-
nisations fund the project leader, the hospitals and nursing
services fund the personnel resources used by the team,
and the research project is funded by a three-year research
grant from the regional health authorities.
Complex interventions have multiple, interacting and
context-dependent active ingredients, which are challen-
ging to identify and keep stable [56]. In this project, the
CCM, with its theoretical rationale, has inspired the de-
sign of the new service model. However, the PACT
model is complex in the sense that each of the ingre-
dients—those of the team and the approach to the
patient—is tailored to the patient and the circumstances
at every point in time. The active ingredient in this pic-
ture cannot be isolated to one single thing. The factors
act synergistically to create a new and sustained practice.
The most stable component is the theoretical concept,
in this case, the CCM, which includes a description of
structures, roles and supporting elements. This means
that fidelity to the theoretical background is an import-
ant measure. In our case, we measure fidelity through
the PACIC questionnaire, which evaluates the chronic
care experiences of patients. However, the final decisions
lie with health care management and not with the re-
searchers. We accommodate this in our design through
a close follow-up of the project, which monitors the
changes and allows sub-analyses to look for effects that
are in line with major changes in the project.
Dedicated, interdisciplinary patient-centred teams can be
a new, more effective and cost-effective way to provide
health care to older patients with long-term complex needs.
Recent studies and reviews underpin the importance of
strategies that support patient involvement, engagement
and self-care [57–59]. The active two-way patient–provider
dialogues and practical skill development in self-
management are reported to be important for better
outcomes [60]. The patient-centred teams will ensure that
several elements of self-management, such as goal setting,
self-monitoring and care plans, will be realised, thereby
providing more insights into the relevance of self-
management in terms of outcomes and cost effectiveness.
In the United Kingdom, the transformation from conven-
tional to patient-centred care in the health system has been
estimated to have a cost-cutting potential of 7 % [61].
The strengths of the present study are its real world
setting and the involvement of designated health profes-
sionals in designing and developing the integrated care
model. The PACT model has been initiated and is solely
driven by managers and clinical personnel at the hospital
and the community services. The structure and organ-
isation of the team and how they work will be continu-
ously adapted to the clinical and everyday routines at
the hospitals and in the home care settings. This might
increase the probability of sustaining the PACT model
after the project has ended.
The main limitation of the study is the lack of ran-
domisation. Although we recognise that randomisation
is the most robust method of avoiding systematic bias
between comparison groups, this method is not possible
in this trial. The PACT model aims to improve geriatric
care in terms of both structures and routines at the or-
ganisational level of two hospitals. A patient-level ran-
domisation, which requires the organisation to switch
between old “usual care” and a new team-based pro-
active care, is unlikely to be successful [56]. Randomis-
ing the organisations could be an alternative, but with
only four hospitals, this is too small to make cluster ran-
domisation meaningful. We are therefore using a
matched control group with before-and-after compari-
sons. This design is approved by Cochrane for use in
systematic reviews of interventions “that cannot be ran-
domized, or which are extremely unlikely to be studied in
randomized trials” [28].
This evaluation study contributes to the research litera-
ture by establishing the effectiveness and cost effectiveness
of proactive, patient-centred team work. Research on how
the PACT model will affect health outcomes, functional
status and health care costs can be useful information for
decision makers in the field. Based on this research, the
local health authorities can make informed decisions
about whether to continue to support and fund the PACT
model. Furthermore, the results can be used to determine
whether the PACT model should be expanded to other
hospitals and municipalities in the region. This research
can also be used as the basis for implementing patient-
centred interdisciplinary teams in other health regions,
both nationally and internationally.
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